ivabradine has been researched along with Dyslipidemias in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolduc, V; Des Rosiers, C; Lachance, D; Lauzier, B; Rivard, ME; Ruiz, M; Shi, Y; Tardif, JC; Thorin, E; Vaillant, F | 1 |
| Bolduc, V; Des Rosiers, C; Drouin, A; Duquette, N; Frayne-Robillard, I; Gillis, MA; Tardif, JC; Thorin, E; Thorin-Trescases, N | 1 |
| Drouin, A; Gendron, ME; Gillis, MA; Mahlberg-Gaudin, F; Tardif, JC; Thorin, E | 1 |
3 other study(ies) available for ivabradine and Dyslipidemias
| Article | Year |
|---|---|
Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Bradycardia; Cardiovascular Agents; Disease Models, Animal; Dyslipidemias; Echocardiography; Energy Metabolism; Female; Glucose; Glycolysis; Heart; Heart Rate; Hemodynamics; Ivabradine; Longitudinal Studies; Male; Metoprolol; Mice; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke Volume; Telemetry; Transcriptome | 2016 |
Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.
Topics: Animals; Anti-Arrhythmia Agents; Apolipoproteins B; Atherosclerosis; Benzazepines; Carotid Arteries; Carotid Artery Diseases; Cerebral Arteries; Cerebrovascular Disorders; Compliance; Disease Models, Animal; Disease Progression; Dyslipidemias; Endothelium, Vascular; Exercise Therapy; Genotype; Heart Rate; Humans; Ivabradine; Male; Matrix Metalloproteinase 9; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase Type III; Phenotype; Receptors, LDL; Severity of Illness Index; Stress, Mechanical; Time Factors; Vasodilation | 2011 |
Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice.
Topics: Acetylcholine; Animals; Apolipoprotein B-100; Benzazepines; Blood Pressure; Cardiotonic Agents; Cerebral Arteries; Dyslipidemias; Endothelium, Vascular; Heart Rate; Ivabradine; Male; Mice; Mice, Inbred C57BL; Renal Artery; Time Factors; Vasodilation | 2008 |